← Open Payments lookup

STEPHEN NEAL: Open Payments

NPI 1609076538 · WAYNESBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,708 in 100 payments from 12 companies in 2025. Trend: 2023 $1,101 · 2024 $1,171 · 2025 $1,708

Food & beverage: $1,708
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$381
Neurocrine BioSciences, Inc.21$309
Vanda Pharmaceuticals Inc.16$234
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$201
Alkermes, Inc.8$157
Janssen Pharmaceuticals, Inc8$137
Axsome Therapeutics, Inc.5$85
Supernus Pharmaceuticals, Inc.4$81
Teva Pharmaceuticals USA, Inc.3$57
Lundbeck LLC2$41

Products named: REXULTI, INGREZZA, CAPLYTA, ARISTADA, FANAPT, INVEGA SUSTENNA, HETLIOZ, Auvelity.

Industry payments across PA — which companies pay providers there.